Episode 23: Inish O'Doherty, PhD, Executive Director, Type 1 Diabetes (T1D) and Transplant Therapeutics (TTC) Consortium at C-Path
2020-10-12
In this episode, Inish O'Doherty joins Monica Westley to discuss his work which focuses on the collaborative selection and development of prognostic biomarkers that can be qualified as Drug Development Tools (DDT) and Novel Methodologies with the FDA and EMA, respectively. Dr. O'Doherty is the Executive Director of C-Path’s Type 1 Diabetes (T1D) and Transplant Therapeutic Consortium (TTC).
To learn more about the ongoing research at C-Path, click on the link below
C-Path Website
More Episodes
Heard on the Street: Tim Tree, PhD, Kings College London
2024-02-22
58
2024-02-22
58
Heard on the Street: Georgia Fousteri, PhD, Dompé
2024-02-21
59
2024-02-21
59
Heard on the Street: Rupangi Vasavada, PhD, City of Hope
2024-02-21
57
2024-02-21
57
Heard on the Street: Yuval Dror, PhD, Hebrew University
2024-02-21
57
2024-02-21
57
Get this podcast on your
phone, FREE
